BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu GJ, Ji Q, Moriyasu F, Xie XY, Wang W, Wong LH, Lin MX, Lu MD. Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats. Ultrasound Med Biol. 2013;39:2158-2165. [PMID: 23969165 DOI: 10.1016/j.ultrasmedbio.2013.05.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Zhang Y, Zhao P, Chen Y, Zhou Y, Wang S, Yin L. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects. Drug Development and Industrial Pharmacy 2020;46:57-69. [DOI: 10.1080/03639045.2019.1701002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Shin HJ, Chang EY, Lee HS, Hong JH, Park G, Kim HG, Kim MJ, Lee MJ. Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstruction. World J Gastroenterol 2015; 21(9): 2614-2621 [PMID: 25759528 DOI: 10.3748/wjg.v21.i9.2614] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Zhang YW, Tu LL, Zhang Y, Pan JC, Zheng GL, Yin LN. Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis. Drug Deliv 2021;28:2534-47. [PMID: 34854788 DOI: 10.1080/10717544.2021.2008054] [Reference Citation Analysis]
4 Morishita K, Hiramoto A, Michishita A, Takagi S, Osuga T, Lim SY, Nakamura K, Sasaki N, Ohta H, Takiguchi M. Washout Ratio in the Hepatic Vein Measured by Contrast-Enhanced Ultrasonography to Distinguish Between Inflammatory and Noninflammatory Hepatic Disorders in Dogs. J Vet Intern Med 2017;31:770-7. [PMID: 28382699 DOI: 10.1111/jvim.14685] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]